
Bioventus BVS
$ 10.41
-1.42%
Annual report 2025
added 03-05-2026
Bioventus P/CF Ratio 2011-2026 | BVS
Annual P/CF Ratio Bioventus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.14 | 15.2 | 22.9 | -6.08 | 25.8 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.8 | -6.08 | 13.2 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 118.25 | -1.27 % | $ 35.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 22.5 | 9.44 % | $ 242 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
19.6 | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.13 | -0.25 % | $ 488 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 28.63 | -1.58 % | $ 20 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
Guardant Health
GH
|
-72.7 | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Celcuity
CELC
|
-35 | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 5.0 | -3.66 % | $ 463 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.24 | -1.91 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.706 | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.62 | -1.23 % | $ 394 M | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Natera
NTRA
|
-12.3 | $ 196.11 | -5.35 % | $ 19.3 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B |